Fundraising FoxIncisive Genetics
Vancouver, CA · 1 known investors
Find your way into Incisive Genetics
Sign up to see every warm intro you have to Incisive Genetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Incisive Genetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Incisive Genetics develops non-viral gene editing therapeutics using proprietary lipid nanoparticle delivery technology to treat genetic diseases by editing genes directly in target tissues. The company focuses initially on Huntington's disease and is advancing toward human clinical trials.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeedJul 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Incisive Genetics do?
- Incisive Genetics develops non-viral gene editing therapeutics using proprietary lipid nanoparticle delivery technology to treat genetic diseases by editing genes directly in target tissues. The company focuses initially on Huntington's disease and is advancing toward human clinical trials.
- Who are Incisive Genetics's investors?
- Incisive Genetics's investors include Saltagen Ventures.
- Where is Incisive Genetics headquartered?
- Incisive Genetics is headquartered in Vancouver, CA.